Skip to content

Epicardial Ablation in Brugada Syndrome. An Extension Study of 500 BrS.Patients

Epicardial Ablation in 500 Consecutive Brugada Syndrome Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03106701
Enrollment
300
Registered
2017-04-10
Start date
2017-03-14
Completion date
2023-12-30
Last updated
2023-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ECG Brugada Pattern

Brief summary

This study represents an extension of a previous study (NCT02641431) on the acute and long-term benefit of epicardial ablation on elimination of both BrS-ECG pattern and VT/VF inducibility in 500 consecutive BrS patients.

Detailed description

According to previous protocol (NCT02641431), 300 additional consecutive selected patients having an ICD implantation will be enrolled up to a total of 500 BrS patients. Echocardiography with cardiac deformation analysis, three-dimensional color-coded voltage, activation and duration electroanatomical maps before and after ajmaline (1mg/kg in 5 minutes) wiil determine the site and the size of the arrhythmogenic substrate as characterized by abnormally prolonged fragmented ventricular potentials and potential wall motion abnormalities. Primary endpoint will be identification and elimination of this electrophysiological substrate by RF applications leading to ECG pattern normalization and VT/VF non-inducibility before and after ajmaline. Patients will be followed up to 10 years after ablation by sequential 12-lead ECG and Holter recording, Echocardiography, ICD interrogation, VT/VF inducibility patterns before and after ajmaline test.

Interventions

PROCEDUREAblation

Epicardial Radiofrequency ablation

Sponsors

IRCCS Policlinico S. Donato
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Symptomatic BrS patients with typical BrS-related symptoms (cardiac arrest or syncope) or without typical BrS-related symptoms (dizziness, palpitations, presyncope, dyspnea) ICD implantation, spontaneous or ajmaline-induced type 1 Br pattern.

Exclusion criteria

* Age \< 18 years, prior epicardial ablation, pregnancy, co-morbidities.

Design outcomes

Primary

MeasureTime frameDescription
Type 1 BrS-ECG pattern elimination by epicardial ablation before and after ajmaline test.1 day after ablationNormalization of ECG pattern after elimination by radio-frequency ablation of all abnormal epicardial potentials
VT/VF inducibilityimmediately after mapping and ablationProgrammed stimulation was achieved at twice the diastolic threshold and randomly performed at RV apex and RV outflow tract using up to 3 drive cycle lengths (from 600 to 350ms) and up to three extrastimuli (S2-S4) delivered from the apex and outflow tract of the right ventricle.
Absence of VT/VF1,3,6,12,18,24,36,48,60,72,84,96,108,120 months after ablationAbsence of VT/VF by ICD interrogation

Secondary

MeasureTime frameDescription
Absence of VA episodes6 monthsICD interrogation
Absence of Br Pattern and RV mechanical abnormalities using echo and cardiac deformation analysis before and after ajmaline test3 monthsAbolition of typical BrS-ECG pattern and RV mechanical abnormalities before and after ajmaline.
Absence of Br ECG pattern after ajmaline test24 monthsNormalization of 12-lead ECG recording at baseline and after ajmaline test
Absence of VA episodes at EP study3 monthsNon-inducibility of VT/VT at programmed electrophysiological study
Absence of Br Pattern at ajmaline test6 monthsNormalization of 12-lead ECG recording and echo parameters at baseline and after ajmaline test

Countries

Italy

Contacts

Primary ContactCarlo Pappone, MD
carlo.pappone@af-ablation.org+39 02 52774260

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026